Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05017194Phase 2Completed
Phase 2, randomised, single-blind trial of emodepside in trichuriasis and hookworm infection (8 arms). Primary endpoints: Cure Rate against Trichuris trichiura and Cure Rate against Hookworm. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05017194.